Anti-Inflammatory Foods and Diet: What Science Says About Foods, Dietary Patterns, and Supplements

Ori Scott, M.Sc., Registered Dietitian (Israel)¹

¹Independent Researcher, New York, NY, USA

Abstract

Background

Chronic low-grade systemic inflammation is associated with obesity, cardiometabolic disease, and other chronic disorders. Diet is increasingly promoted as a strategy for reducing inflammation, yet the popular concept of “anti-inflammatory foods” can obscure important differences between evidence for whole dietary patterns, individual foods, and concentrated nutritional supplements. In addition, changes in circulating inflammatory biomarkers do not necessarily demonstrate prevention or treatment of clinical disease.

Objective

To critically synthesize recent human evidence on the relationships of dietary patterns, individual foods and food groups, and nutritional supplements with biomarkers of systemic inflammation, while distinguishing established findings from supportive or emerging evidence.

Methods

This narrative review prioritized human research indexed in PubMed/MEDLINE, with emphasis on literature published from 2021 through September 2026. Search concepts included inflammation and inflammatory biomarkers in combination with Mediterranean, plant-based and other dietary patterns; olive oil, nuts, whole grains, legumes, berries, coffee, tea, fermented foods, and other food groups; and omega-3 fatty acids, curcumin, ginger, vitamin D, probiotics, prebiotics, and synbiotics. Recent umbrella reviews, systematic reviews and meta-analyses were prioritized, supplemented by randomized controlled trials (RCTs) when needed. Evidence was interpreted according to study design, population, intervention, comparator, biomarker, heterogeneity, and certainty. This was a narrative review and did not use systematic-review screening, formal study-level risk-of-bias assessment, or meta-analysis.

Results

The most consistent recent evidence among dietary patterns supports Mediterranean-style diets. A 2026 umbrella review encompassing 30 reviews and 225 eligible primary studies, focused on adults with at least one chronic condition, found favorable evidence for Mediterranean dietary patterns across C-reactive protein (CRP), interleukin-6 (IL-6), and adiponectin, whereas evidence for most other dietary patterns was limited or inconclusive. A separate meta-analysis of 33 RCTs involving 3,476 participants found reductions in high-sensitivity CRP (hs-CRP), IL-6, and IL-17 with Mediterranean diets but not significant effects on every inflammatory or oxidative-stress marker. Plant-based patterns may reduce CRP, although recent controlled evidence is limited and heterogeneous. Evidence for individual foods is less consistent: benefits vary by food, population, comparator, dose, and biomarker. Recent syntheses of extra-virgin olive oil, nuts, whole grains, legumes, berries, coffee, and tea demonstrate potentially favorable effects for selected outcomes but do not support uniform anti-inflammatory effects. Supplement evidence is distinct from food evidence. Meta-analytic evidence suggests that omega-3 fatty acids, curcumin, ginger, and probiotics can modify selected inflammatory biomarkers, but substantial heterogeneity, formulation differences, population specificity, and uncertainty regarding clinical relevance limit broad therapeutic conclusions. Vitamin D supplementation has not consistently reduced inflammatory biomarkers.

Conclusions

Current evidence supports an overall dietary-pattern approach more strongly than reliance on individual “anti-inflammatory” foods. Mediterranean-style dietary patterns have the most consistent evidence for favorable effects on selected inflammatory biomarkers. Individual foods may contribute to such patterns but generally show heterogeneous, biomarker-specific effects when studied independently. Supplements can alter inflammatory biomarkers in selected settings but should not be assumed equivalent to corresponding foods or to produce clinically meaningful benefits. The most scientifically defensible interpretation is therefore to emphasize overall dietary quality while avoiding claims that any single food or supplement universally “fights inflammation.”

Keywords: anti-inflammatory diet; inflammation; Mediterranean diet; dietary patterns; C-reactive protein; interleukin-6; olive oil; omega-3 fatty acids; curcumin; probiotics; nutrition

1. Introduction

Inflammation is an essential component of normal host defense, tissue repair, and immune regulation. Acute inflammation is generally initiated in response to infection or tissue injury and resolves as the initiating stimulus is controlled. Chronic low-grade inflammation differs from this acute response and is frequently observed in association with obesity, insulin resistance, type 2 diabetes, cardiovascular disease, and other chronic conditions.

The relationship between diet and inflammation has consequently become an important area of nutritional research. At the same time, the term “anti-inflammatory food” has entered popular nutrition discourse and is often used more confidently than the underlying evidence warrants.

Three distinctions are particularly important.

First, dietary patterns are not equivalent to individual foods. A Mediterranean dietary intervention modifies numerous foods simultaneously and may also alter energy intake, fiber intake, fatty-acid composition, micronutrient exposure, food processing, and displacement of other foods. Its effect cannot automatically be assigned to olive oil, vegetables, fish, nuts, or another individual component.

Second, foods are not equivalent to supplements. Concentrated curcumin preparations can deliver exposures very different from culinary turmeric. Purified EPA/DHA preparations differ from fish as a food. A probiotic capsule containing specified microorganisms is not equivalent to yogurt, kefir, kimchi, or another fermented food.

Third, inflammatory biomarkers are not clinical outcomes. CRP, hs-CRP, IL-6, TNF-α, IL-1β, adiponectin, adhesion molecules, and oxidative-stress measures provide useful information about biological processes, but lowering one of these measures does not by itself establish prevention or treatment of cardiovascular disease, cancer, autoimmune disease, dementia, or another clinical condition.

This review therefore examines three separate but related domains: dietary patterns, individual foods and food groups, and supplements or isolated bioactive compounds. The primary emphasis is recent human evidence, particularly systematic reviews, meta-analyses, umbrella reviews, and randomized trials published during the previous five years.

2. Methods

2.1 Review Design and Literature Search

This article was developed as a narrative review designed to provide a critical and interpretive synthesis of recent human evidence on dietary patterns, individual foods and food groups, and nutritional supplements in relation to inflammatory biomarkers. The review was not designed as a systematic review or meta-analysis.

PubMed/MEDLINE was used as the principal biomedical literature database. Literature searching, evidence evaluation, and manuscript development were conducted from June through September 2026. Search concepts combined terms related to inflammation and inflammatory biomarkers with terms for dietary patterns, foods, and supplements. Relevant terms included inflammation, C-reactive protein (CRP), high-sensitivity C-reactive protein (hs-CRP), interleukins, tumor necrosis factor-α (TNF-α), Mediterranean diet, plant-based diet, vegetarian diet, dietary patterns, olive oil, nuts, whole grains, legumes, berries, coffee, tea, fermented foods, omega-3 fatty acids, curcumin, ginger, vitamin D, probiotics, prebiotics, and synbiotics.

The review emphasized human studies published from 2021 through September 2026. The literature search was updated through September 21, 2026, before finalization of the manuscript. Reference lists of relevant reviews and evidence syntheses were also examined when useful for identifying important supporting studies and contextual literature.

2.2 Evidence Selection and Prioritization

Evidence was selected according to its relevance to the review questions and its ability to inform the effects or associations of dietary exposures with inflammatory biomarkers. Priority was given to umbrella reviews and systematic reviews and meta-analyses, particularly those incorporating randomized controlled trials (RCTs). Recent RCTs were considered when higher-level evidence was unavailable, insufficient, or when individual trials provided relevant information not adequately represented in existing evidence syntheses. Prospective observational evidence was considered when randomized evidence was unavailable or not appropriate for the research question. Mechanistic evidence was used primarily to support biological interpretation and was not considered evidence of clinical efficacy.

When multiple reviews or meta-analyses addressed substantially overlapping exposures and outcomes, priority was given to the most recent and directly relevant evidence syntheses, particularly those with clearly defined populations, interventions, comparators, and outcomes; substantial representation of randomized evidence where appropriate; assessment of methodological quality or evidence certainty; and comprehensive evaluation of relevant inflammatory biomarkers. Overlapping reviews were retained when they contributed complementary information regarding populations, interventions, comparators, formulations, biomarkers, or evidence certainty.

Older publications were retained when necessary to provide scientific context or when pivotal earlier trials were incorporated into recent evidence syntheses.

2.3 Evidence Interpretation and Narrative Synthesis

Evidence was interpreted according to study design, population, intervention or exposure, comparator, inflammatory outcome, consistency of findings, statistical heterogeneity, and reported certainty or methodological limitations. Particular attention was given to distinguishing effects on individual inflammatory biomarkers from broader claims regarding systemic inflammation or clinical disease.

Evidence was considered direct when human studies directly evaluated the specified dietary exposure and inflammatory outcome. Evidence was considered supportive or indirect when it informed the relationship but was limited by factors such as observational design, population specificity, heterogeneous interventions, inconsistent biomarker findings, or indirect exposure assessment. Evidence was considered emerging or hypothesis-generating when based on preliminary, small, mechanistic, inconsistent, or otherwise insufficient evidence.

Findings were synthesized narratively rather than quantitatively. Results were compared across dietary patterns, individual foods and food groups, and supplements, with attention to consistency and disagreement among studies and to potential explanations for heterogeneous findings. Evidence from whole foods was not assumed to be equivalent to evidence from isolated compounds or supplements, and changes in inflammatory biomarkers were not interpreted as demonstrating prevention or treatment of clinical disease unless corresponding clinical outcomes had been evaluated.

Because this was a narrative review, the search was not intended to be exhaustive, and formal systematic-review procedures such as duplicate independent screening, a PRISMA flow diagram, protocol registration, independent study-level risk-of-bias assessment, author-performed certainty grading, and original meta-analysis were not undertaken.

3. What Does “Anti-Inflammatory” Mean?

The phrase “reduces inflammation” can imply greater certainty than a nutritional study actually demonstrates.

CRP and hs-CRP are widely used systemic markers. Cytokines such as IL-6 and TNF-α provide additional information, while adiponectin, adhesion molecules, oxidative-stress measures, and other biomarkers address partly different biological processes.

Results across these markers frequently diverge.

This is demonstrated clearly by contemporary Mediterranean-diet evidence. A 2026 meta-analysis of 33 RCTs involving 3,476 participants reported significant reductions in hs-CRP, IL-6, and IL-17 compared with control diets, but did not find significant effects on conventional CRP, IL-10, TNF-α, or total antioxidant capacity.

Therefore, a significant effect on one biomarker should not be generalized to “inflammation” as a whole.

An additional distinction is required between surrogate biomarkers and clinical outcomes. A statistically significant reduction in hs-CRP may support a biological effect, but it does not by itself demonstrate fewer cardiovascular events or improved survival.

4. Dietary Patterns

4.1 Mediterranean Dietary Pattern

Among dietary patterns evaluated in contemporary research, Mediterranean-style diets currently have the most consistent evidence for favorable effects on selected inflammatory biomarkers.

A 2026 umbrella review by Reyneke and colleagues, focused on adults with at least one chronic condition, evaluated 30 reviews representing 225 eligible primary studies, 15 dietary patterns, 60 unique meta-analyses, and 61 narrative syntheses. Mediterranean dietary patterns showed favorable evidence for CRP, IL-6, and adiponectin, with certainty ranging from high to low depending on the outcome. Evidence for vegetarian diets was favorable for CRP but had low-to-very-low certainty; evidence for most other patterns was limited or inconclusive.

The 2026 RCT meta-analysis by Keshani and colleagues strengthens this conclusion while illustrating its boundaries. Across 33 RCTs and 3,476 participants, Mediterranean diets reduced hs-CRP, IL-6, and IL-17 relative to control diets, but significant effects were not observed for all measured outcomes.

These results support the Mediterranean diet as an inflammation-modulating pattern, not as proof that every component independently reduces inflammation.

Typical Mediterranean-style patterns emphasize vegetables, fruits, legumes, nuts, whole grains and olive oil, include fish and other foods in variable amounts, and generally reduce reliance on highly refined foods.

Multiple mechanisms could contribute simultaneously, including altered fatty-acid exposure, greater fiber and phytochemical intake, food substitution, changes in energy balance and adiposity, and effects on metabolic and microbial pathways.

Evidence classification: DIRECT/SUPPORTIVE for selected inflammatory biomarkers.

4.2 Plant-Based and Vegetarian Patterns

Plant-based diets are often described as inherently anti-inflammatory, but the evidence requires greater qualification.

A 2026 systematic review and meta-analysis identified only seven eligible controlled trials, generating eight datasets and including 541 participants. Plant-based dietary patterns were associated with lower CRP compared with omnivorous patterns, but heterogeneity was high and certainty was judged low.

The recent umbrella review likewise found an inverse relationship between vegetarian dietary patterns and CRP, but certainty ranged from low to very low.

These findings are promising but substantially narrower than the claim that any vegetarian or plant-based diet is anti-inflammatory.

The nutritional composition of plant-based diets can vary dramatically. A pattern rich in vegetables, fruits, legumes, nuts, seeds and intact whole grains differs metabolically from one dominated by refined starches, added sugars and highly processed plant-derived products.

Evidence classification: SUPPORTIVE.

4.3 DASH and Other Healthy Dietary Patterns

DASH shares numerous features with Mediterranean eating, particularly high consumption of fruits, vegetables, whole grains, legumes and nuts.

A 2022 systematic review and meta-analysis of RCTs in adults with type 2 diabetes evaluated DASH, Mediterranean, Diabetes Prevention Program, Diabetes UK healthy-eating and American Heart Association Therapeutic Lifestyle Changes patterns. Across 10 RCTs, pooled healthy dietary interventions were associated with lower CRP, although heterogeneity was very high (I² = 94%).

This supports dietary quality as potentially relevant to inflammatory status but does not establish equivalent effects among all dietary patterns.

Evidence classification: SUPPORTIVE, population-specific.

5. Individual Foods and Food Groups

Evidence supporting an overall dietary pattern cannot automatically establish the independent effects of its component foods. Individual-food trials are therefore particularly important for evaluating popular “anti-inflammatory foods.”

5.1 Extra-Virgin Olive Oil

Extra-virgin olive oil (EVOO) is central to Mediterranean dietary patterns and contains predominantly monounsaturated fatty acids together with variable concentrations of phenolic compounds.

A 2024 systematic review and meta-analysis included 33 RCTs and 2,020 participants. EVOO significantly improved insulin and HOMA-IR but produced no significant overall effects on CRP, IL-6, IL-10, or TNF-α.

A more recent systematic review examined 23 RCTs involving 1,138 participants. All included studies had some risk of bias, and certainty ranged from moderate to very low. Higher-phenolic EVOO produced favorable effects on oxidized LDL and, in comparisons with low-phenolic olive oil, CRP, although CRP heterogeneity was substantial.

The apparent discrepancy is informative rather than contradictory: olive-oil effects may depend on phenolic composition, comparator, population and endpoint.

Evidence classification: SUPPORTIVE but heterogeneous.

5.2 Nuts

Nuts provide unsaturated fatty acids, fiber, minerals and phytochemicals, but their inflammatory effects differ across populations and nut types.

A meta-analysis of 18 almond trials involving 847 participants reported modest reductions in CRP and IL-6, but no significant effects on TNF-α, ICAM-1 or VCAM-1. Subgroup results also suggested that effects were not uniform across participant characteristics.

Conversely, a 2024 systematic review in people with established atherosclerotic cardiovascular disease included five randomized trials with 439 participants and found no significant effect of nut supplementation on the evaluated inflammatory profile.

Thus, the statement “nuts reduce inflammation” is too broad.

Evidence classification: SUPPORTIVE/MIXED.

5.3 Whole Grains

Whole grains supply fiber, micronutrients, phytochemicals and fermentable substrates.

A systematic review of 31 RCTs found that only 12 trials demonstrated a significant reduction in at least one inflammatory marker. Among individual comparisons, 10 of 32 CRP analyses, 2 of 18 IL-6 analyses, and 5 of 13 TNF analyses were significant. Benefits appeared more frequently among participants with overweight, obesity, or pre-existing disease.

These findings are compatible with possible anti-inflammatory effects in selected populations but are not evidence of a uniform independent effect.

Evidence classification: SUPPORTIVE/MIXED.

5.4 Legumes

Legumes provide fiber, resistant starch, plant protein, minerals and numerous bioactive compounds.

A 2024 meta-analysis of RCTs examining non-soy legumes among adults with overweight or obesity reported increased adiponectin and reduced IL-1β, but no significant overall effects on CRP, IL-6 or TNF-α.

The finding demonstrates why describing legumes simply as “anti-inflammatory” loses important information: effects differed substantially by biomarker.

Evidence classification: SUPPORTIVE/EMERGING.

5.5 Berries

Berries contain anthocyanins and other polyphenols and are among the foods most frequently promoted for reducing inflammation.

A 2024 systematic review and meta-analysis of raspberry RCTs found a significant reduction in TNF-α but no significant effects on CRP or IL-6. The authors concluded that larger studies were needed.

Berries remain nutrient-dense foods appropriate within healthy dietary patterns, but evidence does not establish a universal anti-inflammatory effect across biomarkers.

Evidence classification: SUPPORTIVE but biomarker-specific.

5.6 Coffee

A 2024 systematic review and meta-analysis evaluated coffee consumption and CRP. Eleven cross-sectional studies involving 66,691 participants contributed to the meta-analysis, and coffee consumption showed a linear inverse association with CRP.

The study design is crucial. Cross-sectional associations cannot establish that coffee consumption caused lower CRP. Lifestyle differences, smoking, health status, reverse causality and other confounders may contribute.

Evidence classification: INDIRECT/SUPPORTIVE.

5.7 Green Tea

Green tea illustrates another distinction between biological plausibility and broad clinical claims.

A 2025 systematic review and dose-response meta-analysis included 38 RCTs. Green-tea supplementation improved IL-1β and several oxidative-stress markers, but did not significantly improve CRP, IL-6 or TNF-α.

Consequently, evidence is stronger for selected oxidative outcomes than for a generalized systemic anti-inflammatory effect.

Evidence classification: MIXED.

5.8 Fermented Foods

Interest in fermented foods has expanded alongside microbiome research, but direct human evidence for systemic anti-inflammatory effects remains comparatively immature.

A 2023 randomized pilot study found differences in selected inflammatory markers when traditionally produced kefir was compared with commercial kefir, but its pilot nature limits generalization.

The biological plausibility of microbiome-mediated effects is substantial, but fermented foods should not yet be presented as established anti-inflammatory therapy.

Evidence classification: EMERGING.

6. Supplements and Isolated Bioactive Compounds

Food and supplement evidence should not be merged. Supplements often provide doses, formulations, extraction methods or microbial strains that bear little resemblance to exposure from ordinary foods.

6.1 Omega-3 Fatty Acids

Long-chain omega-3 fatty acids are among the most extensively investigated nutritional interventions for inflammation.

A 2022 umbrella meta-analysis incorporating 32 meta-analyses found significant reductions in CRP, TNF-α and IL-6 following n-3 PUFA supplementation. However, heterogeneity was substantial: I² values were 89.5% for CRP, 60.1% for TNF-α and 66.2% for IL-6.

These data provide relatively direct evidence for effects on selected biomarkers while simultaneously demonstrating considerable between-study variability.

The findings should not be translated into the proposition that everyone requires fish-oil supplementation or that a biomarker response necessarily produces improved clinical outcomes.

Evidence classification: DIRECT for selected biomarkers; clinical implications remain indication-specific.

6.2 Curcumin

Curcumin is a bioactive constituent of turmeric. Concentrated curcumin formulations used in clinical trials differ substantially from ordinary culinary turmeric exposure.

A 2023 umbrella meta-analysis synthesized 10 meta-analyses representing 5,870 participants and reported significant reductions in CRP, IL-6 and TNF-α. Heterogeneity was substantial for CRP and IL-6.

This supports a biological effect of curcumin supplementation in selected populations. It does not establish equivalent effects from turmeric used as a spice.

Evidence classification: SUPPORTIVE for biomarker modification.

6.3 Ginger

Recent evidence also supports biomarker effects from ginger supplementation.

A 2025 GRADE-assessed systematic review and dose-response meta-analysis included 29 RCTs and reported reductions in CRP, TNF-α and IL-6 together with improvements in several oxidative-stress measures.

The included trials used supplemental interventions; consequently, the findings should not be presented as proof that normal culinary ginger intake produces the same magnitude of effect.

Evidence classification: SUPPORTIVE.

6.4 Vitamin D

Vitamin D provides an important example of why plausible mechanisms and favorable findings in selected populations should not be converted into universal supplementation claims.

A 2024 meta-analysis specifically examined people with overweight or obesity and vitamin D deficiency. Eleven randomized placebo-controlled trials involving 504 participants were included. Vitamin D supplementation did not significantly change CRP, IL-6, or TNF concentrations.

Correction of vitamin D deficiency for appropriate clinical indications is therefore a separate question from prescribing vitamin D specifically as a generalized anti-inflammatory intervention.

Evidence classification: MIXED/POPULATION-SPECIFIC.

6.5 Probiotics, Prebiotics, and Synbiotics

A 2023 umbrella meta-analysis reported reductions in CRP, TNF-α and IL-6 following probiotic supplementation, but heterogeneity was high: approximately 94% for CRP, 76% for TNF-α and 86% for IL-6.

A broader 2024 umbrella review incorporated 24 systematic reviews, 265 unique studies, 1,076 unique effect sizes and 25,973 participants. Although favorable effects were identified across several cardiometabolic and inflammatory outcomes, the credibility of evidence for all evaluated outcomes was classified as class IV.

Probiotics also cannot be considered one homogeneous intervention. Species, strains, combinations, dose, treatment duration and host characteristics differ.

Evidence classification: SUPPORTIVE but highly intervention-specific.

7. Foods Versus Dietary Patterns Versus Supplements

The three exposure categories answer different scientific questions.

Exposure	Scientific strength	Major advantage	Major limitation	Overall interpretation
Dietary patterns	Strongest overall consistency for Mediterranean pattern	Represents real-world eating and food substitution	Difficult to identify responsible components	Best-supported framework
Individual foods	Moderate and heterogeneous	More exposure-specific	Effects often small or biomarker-specific	Useful components, not universal “superfoods”
Supplements	Strong biomarker evidence for selected agents	Precise dose and controlled exposure	May not represent food exposure; clinical relevance uncertain	Potential targeted effects
Mechanistic evidence	Useful for plausibility	Identifies pathways	Does not demonstrate human clinical effectiveness	Explanatory, not confirmatory

The comparison produces an important practical conclusion:

The evidence for an anti-inflammatory dietary pattern is stronger than the evidence for a universal list of anti-inflammatory foods.

That conclusion does not imply that individual foods are irrelevant. Rather, foods appear to be most scientifically meaningful as components of an overall dietary pattern.

8. Summary of Food-Level Evidence

Food/exposure	Recent evidence	Main finding	Evidence interpretation
Extra-virgin olive oil	RCT meta-analyses	Mixed inflammatory results; phenolic content may matter	Supportive/mixed
Almonds/nuts	RCT meta-analyses	Some CRP/IL-6 benefit; no consistent effect across populations/markers	Supportive/mixed
Whole grains	31-RCT systematic review	Only a subset of trials reduced inflammatory markers	Supportive/mixed
Non-soy legumes	RCT meta-analysis	↓ IL-1β, ↑ adiponectin; CRP/IL-6/TNF-α largely unchanged	Supportive/emerging
Raspberries/berries	RCT meta-analysis	↓ TNF-α; no significant CRP or IL-6 effect	Biomarker-specific
Coffee	Observational meta-analysis	Inverse association with CRP	Indirect/supportive
Green tea	38-RCT meta-analysis	↓ IL-1β; no significant CRP, IL-6 or TNF-α effect	Mixed
Fermented foods	Small human trials	Inconsistent and product-specific	Emerging

9. Summary of Supplement Evidence

Supplement	Evidence	Findings	Key caution
Omega-3 fatty acids	Umbrella meta-analysis	↓ CRP, IL-6, TNF-α	Substantial heterogeneity
Curcumin	Umbrella meta-analysis	↓ CRP, IL-6, TNF-α	Supplement ≠ culinary turmeric
Ginger	29-RCT meta-analysis	↓ CRP, IL-6, TNF-α	Supplement doses ≠ ordinary food use
Vitamin D	RCT meta-analysis	No significant CRP/IL-6/TNF effect in overweight/obese vitamin-D-deficient adults	Population-specific
Probiotics	Umbrella analyses	Potential ↓ CRP, IL-6, TNF-α	High heterogeneity; strain specificity
Pre-/synbiotics	Umbrella evidence	Potential cardiometabolic/inflammatory effects	Overall evidence credibility limited

10. Dietary Patterns Associated With Greater Inflammatory Potential

Research has also attempted to characterize diets with greater inflammatory potential.

The Dietary Inflammatory Index (DII) is widely used in observational nutrition research. A 2026 umbrella review examined systematic reviews linking DII scores with numerous health outcomes.

Such findings require careful interpretation. DII studies are frequently observational; consequently, associations between higher DII scores and disease do not demonstrate that the index itself identifies a causal mechanism or that individual foods assigned unfavorable scores independently cause inflammation.

Ultra-processed-food consumption has likewise been associated with adverse health outcomes. A 2025 umbrella review identified 16 publications and reported moderate-certainty associations for several outcomes, including all-cause mortality, cardiovascular disease, type 2 diabetes and colorectal cancer.

Those associations are clinically relevant but should not be interpreted as evidence that inflammation is the sole mechanism connecting ultra-processed foods with disease. Energy density, adiposity, food structure, nutrient displacement and other factors may contribute.

11. Potential Biological Pathways

Several pathways provide biological plausibility for diet–inflammation relationships.

Dietary fiber and resistant starch can influence microbial fermentation and production of metabolites such as short-chain fatty acids. Unsaturated fatty acids can alter membrane lipid composition and lipid-derived signaling. Polyphenols may interact with oxidative and inflammatory signaling pathways. Dietary patterns can influence insulin sensitivity, postprandial metabolism, circulating lipids, adipose-tissue biology and body weight.

Adiposity is especially important because adipose tissue is metabolically and immunologically active. If a dietary intervention causes weight loss, subsequent reductions in inflammatory biomarkers may reflect the loss of adipose tissue, the diet itself, or both.

The gut microbiome provides another plausible pathway, but mechanistic findings require restraint. Changes in microbial composition or metabolites are not automatically evidence of clinically important anti-inflammatory effects.

Figure 1. Conceptual pathway linking diet with inflammatory outcomes

Overall dietary pattern↓Foods and food matrix↓Fiber • fatty acids • phytochemicals • micronutrients • energy density↓Potential intermediate pathways

Gut microbial metabolism ↔ intestinal barrierAdiposity ↔ insulin sensitivityLipid metabolism ↔ oxidative balanceImmune signaling ↔ cytokine regulation

↓Measured biomarkers

CRP/hs-CRP • IL-6 • TNF-α • IL-1β • adiponectin • adhesion molecules

↓Potential clinical outcomes

Interpretive boundary: evidence that an intervention changes a pathway or biomarker does not by itself demonstrate improvement in clinical disease.

12. Food–Supplement Equivalence Is a Scientific Error

One of the most important distinctions for consumer interpretation is that a positive supplement trial cannot automatically support a claim about the corresponding food.

Food	Concentrated intervention	Why they should not be treated as equivalent
Fatty fish	EPA/DHA supplement	Dose and food matrix differ
Turmeric	Curcumin formulation	Concentration and bioavailability differ substantially
Ginger used in cooking	Ginger extract/powder supplement	Trial exposure can greatly exceed culinary use
Fermented foods	Probiotic supplement	Organisms, strains, dose and viability differ
Tea	Concentrated catechin/green-tea preparation	Bioactive exposure differs
Fruits/berries	Polyphenol extract	Whole-food matrix, fiber and other compounds differ

Figure 2. Evidence interpretation framework

Dietary pattern evidence→ asks whether changing the overall diet changes inflammatory outcomes.

Food evidence→ asks whether a particular food independently changes outcomes.

Supplement evidence→ asks whether a specified concentrated compound or formulation changes outcomes.

Mechanistic evidence→ asks whether a biologically plausible pathway exists.

These questions are related, but none can automatically substitute for another.

13. Practical Interpretation

For generally healthy adults, current evidence favors building a high-quality overall diet rather than seeking a single food capable of “fighting inflammation.”

A Mediterranean-style pattern provides the strongest current dietary-pattern evidence. In practical terms, this generally means emphasizing a variety of vegetables and fruits, legumes, nuts and seeds, minimally refined whole grains and unsaturated-fat sources such as olive oil, with fish incorporated where appropriate to the individual's dietary pattern.

This interpretation is stronger than claiming that each component independently lowers inflammatory biomarkers.

Individual foods such as nuts, whole grains, legumes, berries, olive oil, tea and coffee can fit within such a pattern. Their value should not depend solely on whether an isolated trial lowers CRP.

Likewise, evidence supporting a supplement's effect on a biomarker is not sufficient reason for universal supplementation. The appropriate use of omega-3 fatty acids, vitamin D, probiotics or other supplements depends on clinical indication, nutritional status, formulation, dose, medications and individual circumstances.

14. Why “Anti-Inflammatory Superfoods” Is an Inadequate Model

The superfood model has several scientific weaknesses.

First, it ignores substitution. Eating more of one food normally means eating less of another.

Second, it ignores dose. Effects observed using concentrated extracts may be impossible to reproduce through normal food consumption.

Third, it ignores population. An intervention can behave differently in healthy adults, people with obesity, diabetes, cardiovascular disease, or nutritional deficiency.

Fourth, it ignores biomarkers. A food may lower TNF-α while leaving CRP and IL-6 unchanged.

Fifth, it ignores comparator diets. Replacing refined food with nuts is different from adding nuts to an otherwise unchanged diet.

Finally, it encourages mechanistic overinterpretation. Polyphenol content or antioxidant activity alone does not establish clinically meaningful anti-inflammatory efficacy.

15. Research Gaps and Future Directions

Several questions remain unresolved.

Future trials should better standardize intervention composition and comparator diets. Changes in body weight should be reported and considered explicitly when interpreting inflammatory outcomes.

Food trials require better characterization of the intervention itself. Olive oils vary in phenolic content; fermented foods vary in microorganisms; whole grains differ substantially in structure and processing.

Supplement studies require precise formulation reporting. “Probiotics,” “omega-3,” and “curcumin” are not single standardized exposures.

Researchers should also distinguish statistical significance from clinical importance. A small but statistically detectable change in CRP may have uncertain implications for disease risk.

Most importantly, future research should connect biomarker findings with validated clinical endpoints where feasible.

16. Strengths and Limitations

A strength of this narrative review is its emphasis on recent evidence, particularly 2021–2026 systematic reviews, meta-analyses and umbrella reviews. Separating dietary patterns, foods and supplements reduces a common source of conceptual error in nutrition communication.

The review also considers negative and null findings rather than selecting only studies reporting favorable outcomes.

Several limitations should be recognized.

This is a narrative rather than systematic review. Although PubMed/MEDLINE searching and structured evidence prioritization were used, the search should not be interpreted as exhaustive.

No new quantitative meta-analysis was performed.

The review depends partly on existing evidence syntheses and therefore inherits limitations of their included studies, including heterogeneity, overlapping primary trials, variable risk of bias, differences in populations and comparators, and publication bias.

Inflammatory biomarkers differ biologically and analytically, making a single definition of an “anti-inflammatory effect” problematic.

Finally, much of the available literature evaluates surrogate biomarkers rather than clinical inflammatory disease outcomes.

17. Conclusions

Diet influences inflammatory biology, but the common idea of a discrete list of foods that universally “fight inflammation” is not supported by the totality of current human evidence.

Among dietary patterns, Mediterranean-style eating has the most consistent contemporary evidence for favorable effects on selected inflammatory biomarkers. Even here, effects are not universal across CRP, hs-CRP, cytokines, oxidative-stress measures and populations.

Evidence for individual foods is more heterogeneous. Extra-virgin olive oil, nuts, whole grains, legumes, berries, coffee and tea show favorable effects or associations for selected outcomes, but null findings are common and effects frequently differ by biomarker, population and comparator.

Supplement evidence must remain conceptually separate. Omega-3 fatty acids, curcumin, ginger and probiotics can modify selected inflammatory biomarkers in pooled analyses, but heterogeneity and population or formulation differences limit broad therapeutic extrapolation. Vitamin D does not demonstrate a consistent generalized anti-inflammatory effect.

The most defensible nutritional strategy is therefore not to identify a single “best anti-inflammatory food,” but to emphasize overall dietary quality. Individual foods can contribute to that pattern, while supplements should be evaluated separately according to the specific evidence, clinical indication, formulation and individual circumstances.

Above all, a change in an inflammatory biomarker should not be equated automatically with prevention or treatment of inflammatory disease.

Declarations

Funding

This work received no external funding. No third party provided financial or commercial support for the preparation of this review.

Conflicts of Interest

The author is the founder of Healthy Habits Coaching, a nutrition and healthy-habits coaching and educational platform through which the author provides coaching services and publishes health and nutrition educational content, including narrative reviews. Some subject areas addressed by Healthy Habits Coaching overlap with topics discussed in this manuscript.

Healthy Habits Coaching did not provide external sponsorship for this review, and no third party provided financial or commercial support for its preparation. The author's relationship with Healthy Habits Coaching is disclosed for transparency as a potential commercial and/or non-financial interest. The author reports no other conflicts of interest relevant to this manuscript.

Author Contributions

Ori Scott: Conceptualization; Methodology; Investigation; Validation; Writing—original draft; Writing—review and editing; Project administration.

Ori Scott conceived the review topic and scope, defined the research questions and evidence-selection framework, evaluated the scientific relevance of the literature and the interpretation of the evidence, prepared and critically revised the manuscript, and approved the final version. The author accepts full responsibility for the integrity and final content of the work.

Ethics Statement

Ethics approval was not required because this narrative review is based exclusively on previously published literature and involved no recruitment of human participants, collection of identifiable personal information, or original research involving human participants or animals.

Patient Consent

Not applicable. The manuscript contains no original participant data, identifiable patient information, or clinical images requiring patient consent.

Consent for Publication

Not applicable.

Data Availability

No original participant-level data or research dataset was generated for this narrative review. The evidence discussed in the manuscript is derived from published literature cited in the reference list.

Acknowledgements

None.

Artificial Intelligence–Assisted Editing

AI-assisted tools were used for limited editorial assistance, including language editing, spelling correction, and formatting. The author reviewed and approved the final manuscript and takes full responsibility for its content.

References

1. Reyneke GL, Lambert K, Beck EJ. Dietary Patterns Associated With Anti-inflammatory Effects: An Umbrella Review of Systematic Reviews and Meta-analyses. Nutr Rev. 2026;84(6):1167–1192. doi:10.1093/nutrit/nuaf104. PMID: 40657695.

2. Keshani M, Rafiee S, Heidari H, et al. Mediterranean Diet Reduces Inflammation in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Nutr Rev. 2026;84(9):1776–1790. doi:10.1093/nutrit/nuaf213. PMID: 41211687.

3. Bell L, Gibbs J, Cappuccio FP. The effect of plant-based dietary patterns on C-reactive protein: A systematic review and meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis. 2026;36(7):104631. doi:10.1016/j.numecd.2026.104631. PMID: 41856828.

4. Sánchez-Rosales AI, Guadarrama-López AL, Gaona-Valle LS, Martínez-Carrillo BE, Valdés-Ramos R. The Effect of Dietary Patterns on Inflammatory Biomarkers in Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2022;14(21):4577. doi:10.3390/nu14214577. PMID: 36364839.

5. Morvaridzadeh M, Cohen AA, Heshmati J, et al. Effect of Extra Virgin Olive Oil on Anthropometric Indices, Inflammatory and Cardiometabolic Markers: a Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Nutr. 2024;154(1):95–120. doi:10.1016/j.tjnut.2023.10.028. PMID: 37977313.

6. Damasceno JV, Garcez A, Alves AA, et al. Effects of daily extra virgin olive oil consumption on biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2026;66(2):392–408. doi:10.1080/10408398.2025.2525446. PMID: 40749711.

7. Fatahi S, Daneshzad E, Lotfi K, Azadbakht L. The Effects of Almond Consumption on Inflammatory Biomarkers in Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Adv Nutr. 2022;13(5):1462–1475. doi:10.1093/advances/nmab158. PMID: 34967837.

8. Bersch-Ferreira AC, Stein E, Waclawovsky G, et al. Effect of nuts on lipid profile and inflammatory biomarkers in atherosclerotic cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Nutr. 2024;63(7):2391–2405. doi:10.1007/s00394-024-03455-2. PMID: 38967674.

9. Milesi G, Rangan A, Grafenauer S. Whole Grain Consumption and Inflammatory Markers: A Systematic Literature Review of Randomized Control Trials. Nutrients. 2022;14(2):374. doi:10.3390/nu14020374. PMID: 35057555.

10. Mansouri F, de Simone G, Bordoni L, Gabbianelli R. The effects of nonsoy legumes consumption on serum levels of inflammatory biomarkers and adiponectin in overweight/obese adults: A systematic review and meta-analysis of randomized controlled trials. J Nutr Biochem. 2024;133:109718. doi:10.1016/j.jnutbio.2024.109718. PMID: 39103105.

11. Shahraki Jazinaki M, Nosrati M, Chambari M, Jamialahmadi T, Sahebkar A. The Effects of Raspberry Consumption on Glycemic Control and Inflammation Markers in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr Dev Nutr. 2024;8(6):102161. doi:10.1016/j.cdnut.2024.102161. PMID: 38860149.

12. Choi S, Je Y. Coffee consumption and C-reactive protein levels: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2024;34(11):2425–2439. doi:10.1016/j.numecd.2024.06.024. PMID: 39179502.

13. Dehzad MJ, Ghalandari H, Nouri M, Makhtoomi M, Askarpour M. Effects of green tea supplementation on antioxidant status and inflammatory markers in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomised controlled trials. J Nutr Sci. 2025. doi:10.1017/jns.2025.13. PMID: 40160899.

14. Bourrie BCT, Forgie AJ, Makarowski A, et al. Consumption of kefir made with traditional microorganisms resulted in greater improvements in LDL cholesterol and plasma markers of inflammation in males when compared to a commercial kefir: a randomized pilot study. Appl Physiol Nutr Metab. 2023;48(9):668–677. doi:10.1139/apnm-2022-0463. PMID: 37224566.

15. Kavyani Z, Musazadeh V, Fathi S, et al. Efficacy of the omega-3 fatty acids supplementation on inflammatory biomarkers: An umbrella meta-analysis. Int Immunopharmacol. 2022;111:109104. doi:10.1016/j.intimp.2022.109104. PMID: 35914448.

16. Naghsh N, Musazadeh V, Nikpayam O, et al. Profiling Inflammatory Biomarkers following Curcumin Supplementation: An Umbrella Meta-Analysis of Randomized Clinical Trials. Evid Based Complement Alternat Med. 2023;2023:4875636. doi:10.1155/2023/4875636. PMID: 36700039.

17. Rjabi S, Barbarz H, Makhtoomi M, et al. Antioxidant and anti-inflammatory effects of ginger supplementation in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomised controlled trials. Inflammopharmacology. 2025;33(12):7197–7216. doi:10.1007/s10787-025-01994-6. PMID: 41123858.

18. Gouveia HJCB, da Silva MM, de Castro RM, et al. Vitamin D supplementation does not alter inflammatory markers in overweight and obese individuals: A systematic review and meta-analysis of randomized controlled trials. Nutr Res. 2024;128:24–37. doi:10.1016/j.nutres.2024.06.005. PMID: 39002359.

19. Faghfouri AH, Gol Mohammad Pour Afrakoti L, Kavyani Z, et al. The role of probiotic supplementation in inflammatory biomarkers in adults: an umbrella meta-analysis of randomized controlled trials. Inflammopharmacology. 2023;31(5):2253–2268. doi:10.1007/s10787-023-01332-8. PMID: 37698776.

20. Teo YQJ, Chong B, Soong RY, Yong CL, Chew NWS, Chew HSJ. Effects of probiotics, prebiotics and synbiotics on anthropometric, cardiometabolic and inflammatory markers: An umbrella review of meta-analyses. Clin Nutr. 2024;43(6):1563–1583. doi:10.1016/j.clnu.2024.05.019. PMID: 38754308.

21. Gkesou V, Theodoridis X, Papaemmanouil A, et al. The association of dietary inflammation index (DII) and health-related outcomes: An umbrella review of systematic reviews. Clin Nutr ESPEN. 2026;75:103590. doi:10.1016/j.clnesp.2026.103590. PMID: 42435895.

22. Barbaresko J, Bröder J, Conrad J, et al. Ultra-processed food consumption and human health: an umbrella review of systematic reviews with meta-analyses. Crit Rev Food Sci Nutr. 2025;65(11):1999–2007. doi:10.1080/10408398.2024.2317877. PMID: 38363072.